SkinBioTherapeutics Plc (SBTX.L)

GBp 20.05

(-2.2%)

EBITDA Summary of SkinBioTherapeutics Plc

SkinBioTherapeutics Plc's latest annual EBITDA in 2022 was -2.95 Million GBP , down -0.13% from previous year.
SkinBioTherapeutics Plc's latest quarterly EBITDA in 2023 Q2 was -1.36 Million GBP , down 0.0% from previous quarter.
SkinBioTherapeutics Plc reported an annual EBITDA of -2.95 Million GBP in 2021, down -98.17% from previous year.
SkinBioTherapeutics Plc reported an annual EBITDA of -1.49 Million GBP in 2020, up 7.78% from previous year.
SkinBioTherapeutics Plc reported a quarterly EBITDA of -1.62 Million GBP for 2022 Q4, down 0.0% from previous quarter.
SkinBioTherapeutics Plc reported a quarterly EBITDA of -1.33 Million GBP for 2022 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of SkinBioTherapeutics Plc (2022 - 2015)

Historical Annual EBITDA of SkinBioTherapeutics Plc (2022 - 2015)

Year	EBITDA	EBITDA Growth
2022	-2.95 Million GBP	-0.13%
2021	-2.95 Million GBP	-98.17%
2020	-1.49 Million GBP	7.78%
2019	-1.61 Million GBP	-19.15%
2018	-1.35 Million GBP	-44.01%
2017	1.00 GBP	-104.06%
2016	-168.79 Thousand GBP	-143136.65%
2015	-323.00 GBP	0.0%

Year	EBITDA	EBITDA Growth
2023 Q2	-1.36 Million GBP	0.0%
2022 Q4	-1.62 Million GBP	0.0%
2022 Q2	-1.33 Million GBP	0.0%
2022 FY	- GBP	-0.13%
2021 Q2	-1.14 Million GBP	0.0%
2021 FY	- GBP	-98.17%
2021 Q4	-1.8 Million GBP	0.0%
2020 Q2	-626.54 Thousand GBP	0.0%
2020 FY	- GBP	7.78%
2020 Q4	-865.52 Thousand GBP	0.0%
2019 Q4	-728.49 Thousand GBP	0.0%
2019 FY	- GBP	-19.15%
2019 Q2	-886.45 Thousand GBP	0.0%
2018 Q4	-725.65 Thousand GBP	0.0%
2018 FY	- GBP	-44.01%
2018 Q2	-631.42 Thousand GBP	0.0%
2017 FY	- GBP	-104.06%
2017 Q4	107.1 Thousand GBP	0.0%
2017 Q2	86.95 Thousand GBP	0.0%
2016 Q3	-168.17 Thousand GBP	-566.43%
2016 FY	- GBP	-143136.65%
2016 Q2	-25.23 Thousand GBP	-60.79%
2016 Q1	-15.69 Thousand GBP	0.0%
2016 Q4	-116.41 Thousand GBP	30.78%
2015 FY	- GBP	0.0%

Peer EBITDA Comparison of SkinBioTherapeutics Plc

Name	EBITDA	EBITDA Difference